Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11723972 | Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 | Margaret A. Shipp, Jing Ouyang, Kunihiko Takeyama, Jeffery L. Kutok, Gabriel Rabinovich +2 more | 2023-08-15 |
| 11673956 | Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1 | Margaret A. Shipp, Jing Ouyang | 2023-06-13 |
| 10948492 | PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers | Adam Bass, Sarah Derks, Gordon J. Freeman | 2021-03-16 |
| 10844126 | Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1 | Margaret A. Shipp, Jing Ouyang | 2020-11-24 |
| 10519238 | Anti-galectin-1 monoclonal antibodies and fragments thereof | Margaret A. Shipp, Jing Ouyang | 2019-12-31 |
| 10456465 | Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 | Margaret A. Shipp, Jing Ouyang, Kunihiko Takeyama, Jeffery L. Kutok, Gabriel Rabinovich +2 more | 2019-10-29 |
| 9939428 | Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 | Margaret A. Shipp, Przemyslaw Juszczynski, Jing Ouyang, Jeffery L. Kutok, Gabriel Rabinovich | 2018-04-10 |
| 9890429 | Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer | Margaret A. Shipp, Stefano Monti, Bjoern Chapuy, Todd Golub | 2018-02-13 |
| 9206427 | Compositions, kits, and methods for the modulation of immune responses using galectin-1 | Margaret A. Shipp, Przemyslaw Juszczynski, Jing Ouyang, Jeffery L. Kutok, Gabriel Rabinovich | 2015-12-08 |
| 8968740 | Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 | Margaret A. Shipp, Jing Ouyang, Kunihiko Takeyama, Jeffery L. Kutok, Gabriel Rabinovich +2 more | 2015-03-03 |